Esther H Chang

USPTO Granted Patents = 16 (Patent Applications = 4)

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 86(Granted Patents)

Location History:

Chevy Chase, MD (US) (2000 - 2014)
Potomac, MD (US) (2013 - 2024)

Company Filing History:

14 out of 485

Georgetown University

patents

3 out of 3

Synergene Therapeutics, Inc.

patents

1 out of 330

Aventis Pharma Deutschland, Gmbh

patents

4. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12274784 - Methods for reducing side effects of immunotherapy (2025-04-14),

2. 11951167 - Targeted liposomes (2024-04-09),

3. 10668172 - Treatment for exposure to nerve agent (2020-06-02),

4. 9878055 - Treatment for exposure to nerve agent (2018-01-30),

5. 9480750 - Preparation of antibody or an antibody fragment targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof (2016-11-01),

6. 9034330 - Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof (2015-05-19),

7. 9034329 - Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof (2015-05-19),

8. 8865127 - Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent (2014-10-21),

9. 8859274 - Antibody fragment-targeted immunoliposomes for systemic gene delivery (2014-10-14),

10. 8617514 - Tumor-targeted nanodelivery systems to improve early MRI detection of cancer (2013-12-31),

11. 7780882 - Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent (2010-08-24),

12. 7479276 - Antibody fragment-targeted immunoliposomes for systemic gene delivery (2009-01-20),

13. 6803360 - Compositions and methods for reducing radiation and drug resistance in cells (2004-10-12),

14. 6749863 - Targeted liposome gene delivery (2004-06-15),

15. 6723706 - Modified antisense nucleotides complementary to a section of the human Ha-ras gene (2004-04-20),

Title: The Innovative Journey of Esther H Chang

Introduction: Esther H Chang, a pioneering inventor based in Potomac, MD (US), has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Esther H Chang holds several patents in the areas of artificial intelligence, renewable energy, and healthcare technology, showcasing her diverse range of expertise and innovative spirit.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Esther H Chang has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout her career, Esther H Chang has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life, demonstrating her ability to work effectively in multidisciplinary teams.

Conclusion: Esther H Chang's relentless pursuit of innovation and her commitment to pushing the boundaries of technology make her a true trailblazer in the world of inventions. Her impact continues to inspire future generations of inventors to think boldly and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.